MSTN and sarcopenia: The purpose of Yen et al.’s work was also to identify a biomarker useful in the diagnosis of sarcopenia by analyzing coenzyme Q10, creatine kinase, albumin, irisin, myostatin in sarcopenic and non-sarcopenic patients [46].